Case report reveals risks of hepatotoxicity in patients with alcohol use disorder, highlighting the need for careful patient selection.
Disulfiram can cause severe and potentially fatal hepatotoxicity, particularly in patients with preexisting liver disease. In Bhutan, where alcohol‐related liver disease represents a major public health burden and pharmacological options for relapse prevention remain limited, careful patient selection, hepatic assessment, and early monitoring are essential prior to initiating disulfiram therapy.
No takes yet. Share an insight, caveat, or question.
Wangchuk et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: